Literature DB >> 8597615

Thromboembolism in a patient with transient eosinophilia.

H Y Mukai1, H Ninomiya, S Mitsuhashi, Y Hasegawa, T Nagasawa, T Abe.   

Abstract

We report here a case of thromboembolism occurring in a 29-year-old woman with transient eosinophilia. Eosinophilia for at least 11 days was followed by pulmonary embolism. Both reperfusion of pulmonary arteries and disappearance of deep vein thrombi were obtained by treatment with urokinase, tissue plasminogen activator, and heparin. Although the causes of eosinophilia were not specified, we suggested a causative correlation of elevated serum levels of eosinophil granule proteins with the development of thromboembolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8597615     DOI: 10.1007/bf00641316

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  16 in total

1.  [A case of hypereosinophilic syndrome associated with pulmonary infarction and hepatic vein obstruction (Budd-Chiari syndrome)].

Authors:  N Suenaga; F Hayashi; N Miyauhi; H Nakamura; O Kitada; M Sugita; K Uematsu; M Kitaichi
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1991-02

2.  Pulmonary eosinophilia.

Authors:  J W CROFTON; J L LIVINGSTONE; N C OSWALD; A T M ROBERTS
Journal:  Thorax       Date:  1952-03       Impact factor: 9.139

Review 3.  The eosinophilic pneumonias.

Authors:  A A Liebow; C B Carrington
Journal:  Medicine (Baltimore)       Date:  1969-07       Impact factor: 1.889

Review 4.  The idiopathic hypereosinophilic syndrome.

Authors:  P F Weller; G J Bubley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

5.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Authors:  C T Esmon; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

6.  Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents.

Authors:  O D Ratnoff; G J Gleich; S B Shurin; J Kazura; B Everson; P Embury
Journal:  Am J Hematol       Date:  1993-01       Impact factor: 10.047

7.  Hepatic vein obstruction in idiopathic hypereosinophilic syndrome.

Authors:  L Elouaer-Blanc; E S Zafrani; J P Farcet; M F Saint-Marc Girardin; D Mathieu; D Dhumeaux
Journal:  Arch Intern Med       Date:  1985-04

8.  Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia.

Authors:  H Y Mukai; H Ninomiya; K Ohtani; T Nagasawa; T Abe
Journal:  Br J Haematol       Date:  1995-08       Impact factor: 6.998

Review 9.  Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia.

Authors:  K Takai; M Sanada
Journal:  Int J Hematol       Date:  1991-06       Impact factor: 2.490

10.  Deficiency of protein C in congenital thrombotic disease.

Authors:  J H Griffin; B Evatt; T S Zimmerman; A J Kleiss; C Wideman
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more
  3 in total

1.  Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma.

Authors:  Demet Karnak; Oya Kayacan; Sumru Beder; Mustafa Delibalta
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

2.  Eosinophilia and first-line coagulation testing.

Authors:  Giuseppe Lippi; Martina Montagnana; Gian Luca Salvagno; Massimo Franchini; Giovanni Targher; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2008-07-10       Impact factor: 2.300

Review 3.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.